LATEST ALERTS
Tighter regulation “is on the way” for e-cigs, according to the European Commission’s commissioner for health and food safety, Vytenis Andriukaitis, who sees “possibilities” for “stronger regulation” to “stop advertising and online sales”
As PMI’s iQOS comes under consideration by the US FDA, we examine the hurdles it – and other – heated tobacco and e-cigarette products will have to clear to obtain authorisation for commercialisation and reduced-risk claims.
Heated tobacco products may have an advantage in the EU over both cigarettes and e-cigs as the devices are not classed as tobacco products. It remains to be seen how each country allows them to be promoted
More than a tenth of Italians trying to give up smoking (10.7%) use e-cigarettes to help them – more than any other cessation aids – but the vast majority use no aid at all
A move by the US FDA to reduce the nicotine content in cigarettes to non-addictive levels could encourage Big Tobacco to put yet more effort into alternatives
Major Australian public health organisations have submitted evidence to a government inquiry on e-cigarettes, with many taking a negative stance
Scott Gottlieb, commissioner of the US FDA, appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction
UK Department of Health wants e-cigs excluded from smoke-free policies, a clear path to medical licensing – and maybe even a review of Britain’s TPD law
New research shines a little light on how Japanese consumers are reacting to iQOS, and how HnB products compare with both combustibles and e-cigarettes on the crucial question of nicotine delivery.
Raising taxes on e-cigarette products would cause an increase in cross-border sales and lead to some users taking up smoking again, users told a European consultation on excise duty.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it streamlines access to critical market and regulatory insights
"*" indicates required fields
